# Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF)

> **NCT07121751** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Dunamenti REK Istenhegyi IVF Center** · enrollment: 150 (estimated)

## Conditions studied

- Hypo-responder
- Infertility (IVF Patients)
- OVARIAN STIMULATION

## Interventions

- **DRUG:** use of combination of recombinant FSH and recombinant LH
- **DRUG:** higher dose recFSH
- **DRUG:** unchanged dose

## Key facts

- **NCT ID:** NCT07121751
- **Lead sponsor:** Dunamenti REK Istenhegyi IVF Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-08-31
- **Final completion:** 2027-03-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-08-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07121751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07121751, "Optimal Stimulation of Hypo-responders Undergoing in Vitro Fertilization (IVF)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07121751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*